Wei Shen
About
In The Last Decade
Wei Shen
108 papers receiving 5.5k citations
Peers
Comparison fields: 5 of 146
- Electrical and Electronic Engineering 1.8k
- Electronic, Optical and Magnetic Materials 1.2k
- Materials Chemistry 1.2k
- Molecular Biology 938
- Biomaterials 674
Countries citing papers authored by Wei Shen
This map shows the geographic impact of Wei Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Shen more than expected).
Fields of papers citing papers by Wei Shen
This network shows the impact of papers produced by Wei Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Shen. The network helps show where Wei Shen may publish in the future.
Co-authorship network of co-authors of Wei Shen
This figure shows the co-authorship network connecting the top 25 collaborators of Wei Shen. A scholar is included among the top collaborators of Wei Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Shen. Wei Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 36 | |
| 3 | 78 | |
| 4 | 80 | |
| 5 | 29 | |
| 6 | 21 | |
| 7 | 1 | |
| 8 | 9 | |
| 9 | 33 | |
| 10 | Novel mutation in FBN1 causes ectopia lentis and varicose great saphenous vein in one Chinese autosomal dominant family. | 4 |
| 11 | 2 | |
| 12 | Establishment of a rat model of nephrosis induced by single tail vein injection of doxorubicin | 2 |
| 13 | 151 | |
| 14 | 174 | |
| 15 | 1 | |
| 16 | 99 | |
| 17 | 17 | |
| 18 | 226 | |
| 19 | 3 | |
| 20 | 34 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.